Description
BT-13 is a potent and selective agonist of RET tyrosine kinase and its downstream signaling cascades. BT-13 promotes neurite growth from sensory neurons in vitro and attenuates experimental neuropathy in the Rat.
BT-13 is a potent and selective agonist of RET tyrosine kinase and its downstream signaling cascades. BT-13 promotes neurite growth from sensory neurons in vitro and attenuates experimental neuropathy in the Rat.
Alternate Name/Synonyms: BT13, N,N-Diethyl-3-[4-[4-fluoro-2-(trifluoromethyl)benzoyl]-1-piperazinyl]-4-methoxybenzenesulfonamide
Appearance: White to off-white solid
Formulation:
CAS Number: 924537-98-4
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₃H₂₇F₄N₃O₄S
Molecular Weight: 517.54
Cell-Permeable?: True
Purity: ≥98% by HPLC
Solubilities: >20 mg/ml in DMSO
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: A potent RET agonist
MDL Number:
PubChem CID: 46088379
SMILES: CCN(CC)S(=O)(=O)C1=CC(=C(C=C1)OC)N2CCN(CC2)C(=O)C3=C(C=C(C=C3)F)C(F)(F)F
InChi: InChI=1S/C23H27F4N3O4S/c1-4-30(5-2)35(32,33)17-7-9-21(34-3)20(15-17)28-10-12-29(13-11-28)22(31)18-8-6-16(24)14-19(18)23(25,26)27/h6-9,14-15H,4-5,10-13H2,1-3H3
InChi Key:
Additional Information
Storage Condition: |
-20ºC |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |